Lupin Seeks To Preempt Claim Over Ramipril Patent
Generics drugmaker Lupin Ltd. has asked a judge to find it doesn't infringe a patent licensed to rival King Pharmaceuticals Inc. for the hypertension drug Altace, several months after winning a...To view the full article, register now.
Already a subscriber? Click here to view full article